Oncorus Overview

  • Founded
  • 2015
Founded
  • Status
  • Public
  • Employees
  • 51
Employees
  • Stock Symbol
  • ONCR
Stock Symbol
  • Share Price
  • $14.11
  • (As of Friday Closing)

Oncorus General Information

Description

Oncorus Inc is a clinical stage biopharmaceutical company focused on developing viral immunotherapies to transform outcomes for cancer patients. The company is in the process of developing intratumorally and intravenously administered product candidates designed to selectively attack and kill tumor cells and stimulate multiple arms of the immune system against tumors.

Contact Information

Website
www.oncorus.com
Ownership Status
Publicly Held
Financing Status
Formerly VC-backed
Primary Industry
Drug Discovery
Other Industries
Biotechnology
Pharmaceuticals
Stock Exchange
NAS
Primary Office
  • 50 Hampshire Street
  • Suite 401
  • Cambridge, MA 02139
  • United States
+1 (857) 000-0000
Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial
Want to dig into this profile?

We’ll help you find what you need

Learn more

Oncorus Stock Performance

(As of Friday Closing)

Stock Price Previous Close 52 wk Range Market Cap Shares Average Volume EPS
$14.11 $13.91 $13.05 - $37.86 $361M 25.6M 152K -$5.08

Oncorus Financials Summary

In Thousands,
USD 		TTM 30-Sep-2020 FY 2019 31-Dec-2019 FY 2018 31-Dec-2018
Revenue 0 0 0
EBITDA (44,647) (30,142) (17,318)
Net Income (45,599) (30,704) (18,046)
Total Assets 62,059 50,826 25,656
Total Debt 0 0 0
Public Fundamental Data provided by Morningstar, Inc. disclaimer

Oncorus Valuation & Funding

Deal Type Date Amount Valuation/
EBITDA		 Post-Val Status Debt

This information is available in the PitchBook Platform. To explore Oncorus‘s full profile, request access.

Request a free trial

Oncorus Cap Table

Stock # of Shares
Authorized		 Par Value Dividend Rate (%) Original
Issue Price		 Liquidation Liquidation
Pref. Multiple		 Conversion
Price		 % Owned

This information is available in the PitchBook Platform. To explore Oncorus‘s full profile, request access.

Request a free trial

Oncorus Comparisons

Description
Primary
Industry
HQ Location
Employees
Total Raised
Post Valuation
Last Financing Details
Oncorus Inc is a clinical stage biopharmaceutical company focused on developing viral immunotherapies to transform outco
Drug Discovery
Cambridge, MA
51 As of 2020
00000
00000000 00000

00000 00

orem ipsum dolor sit amet, consectetur adipiscing elit, sed do eiusmod tempor incididunt ut labore e
000000000000000
Cambridge, MA
00 As of 0000
00000
00000000000 00000

00000 00

t aliquip ex ea commodo consequat. Duis aute irure dolor in reprehenderit in voluptate velit esse ci
0000 000000000
Watertown, MA
00 As of 0000
00.000
00000000 00.000
Add Comparison

PitchBook’s comparison feature gives you a side-by-side look at key metrics for similar companies. Personalize which data points you want to see and create visualizations instantly.

Request a free trial

Oncorus Competitors (55)

Company Name Financing Status Location Employees Total Raised Last Financing Date/Type Last Financing Amount
Sesen Bio Formerly VC-backed Cambridge, MA 00 00000 00000000000 00000
00000 000000000000 Formerly VC-backed Watertown, MA 00 00.000 00000000 00.000
0000000 Venture Capital-Backed San Diego, CA 00 00.000 0000000000 0 00.000
0000000 Venture Capital-Backed Houston, TX 00 000.00 000000000 - 000.00
00000 Private Equity-Backed San Diego, CA 00 00000 0000000 0000 00000
You’re viewing 5 of 55 competitors. Get the full list »

Oncorus Executive Team (10)

Name Title Board Seat Contact Info
Theodore Ashburn Ph.D Chief Executive Officer & Board Member
John McCabe Chief Financial Officer, Finance & Chief Accounting Officer, Accounting
Stephen Harbin Chief Operating Officer, Operations & Executive
Christophe Quéva Ph.D Chief Scientific Officer and Senior Vice President of Research
Eric Sullivan Senior Vice President, Finance & Operations, Treasurer
You’re viewing 5 of 10 executive team members. Get the full list »

Oncorus Board Members (12)

Name Representing Role Since
Alon Lazarus Ph.D Self Board Member 000 0000
Briggs Morrison MD MPM Capital Board Member 000 0000
Cameron Wheeler Ph.D Deerfield Management Board Member 000 0000
Luke Evnin Ph.D MPM Capital Board Member 000 0000
Mary Fenton Oncorus Board Member 000 0000
You’re viewing 5 of 12 board members. Get the full list »

Oncorus Signals

Growth Rate

0.80% Weekly
Growth
Weekly Growth 0.80%, 93rd %ile
-35.5%. 530%

Size Multiple

219x Median
Size Multiple 219x, 100th %ile
0.00x 0.95x. 413Kx

Key Data Points

Twitter Followers

5.5k

Similarweb Unique Visitors

15.0K

Majestic Referring Domains

314

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

Oncorus Investors

Investor Name Investor Type Holding Investor Since Participating Rounds Contact Info

This information is available in the PitchBook Platform. To explore Oncorus‘s full profile, request access.

Request a free trial